This protocol was developed for practitioners using Fullscript in Canada and the templates cannot be applied to accounts operating outside of Canada


1 tsp mixed in water twice daily. Consult a healthcare professional for use beyond 14 days.

Broncha contains a combination of traditional herbs that provide support for the lungs and bronchials. The herbs act to decrease respiratory inflammation, loosen mucous and increase expectoration (bring up and expel mucous from the bronchials and lungs), and reduce and relieve coughs.

The herbs in Broncha are traditionally used in herbal medicine for:

  • Thyme, English Ivy – to help relieve coughs (1)(3)(4)(5)(6)
  • Thyme, English Ivy, Fennel – to help reduce and relieve coughs associated with colds and bronchitis (1)(2)
  • Thyme, English Ivy, Fennel – to help relieve symptoms of bronchitis and loosen mucous buildup of the upper respiratory tract (1)(3)(4)(6)(7)(8)

Key features:

  • Improves symptoms of acute and chronic bronchitis
  • Increases ability to expel or expectorate mucous from the lungs and bronchial tract
  • Loosens mucous buildup in the respiratory tract (expectorant and anti-catarrh)
  • Reduces and relieves coughs (antitussive and anti-spasmolytic)
  • Reduces inflammation of the respiratory system (lungs and bronchial)
  • Supports lung and bronchial health
  • Supports respiratory health


1 capsule taken on an empty stomach once daily. Consult a healthcare professional for use beyond 7 days.

Serrapeptase is a proteolytic and mucolytic enzyme. The proteolytic enzyme properties reduce pain, swelling, edema, congestion, and inflammation (9)(10)(11) associated with the upper respiratory tract. The mucolytic enzyme properties thin (reduces viscosity) and break up (improve quality and elimination of secretions) mucous and biofilm matrix formations. (10)(12)(13)(14)(15)(16)

Serrapeptase reduces inflammation and breaks up/eliminates mucous.

Serrapeptase helps relieve respiratory symptoms of:

  • Ear, nose, throat, and upper respiratory tract infections (15)(16)
  • Otitis, rhinitis, sinusitis, and bronchitis (9)(10)(14)
  • Pain, stuffiness, congestion, and diminished or loss of smell (15)(16)
  • Coughs, colds, and allergies (14)

Key features:

  • Breaks up biofilm formation
  • Improves symptoms associated with sinusitis, bronchitis, cough, colds, and allergies
  • Mucolytic and proteolytic enzymes
  • Reduces inflammation and breaks up mucous
  • Reduces pain, stuffiness, and congestion in infections of the ears, nose, sinuses, throat, and lungs
  • Supports lung and bronchial health
  • Supports respiratory health
  • Thins and breaks up mucous in upper respiratory infections

Bio C (with Lipid Metabolites and Citrus Bioflavonoids)

1-3 capsules daily. Safe to use long term.

Vitamin C supports immune function, reduces inflammation, and is a potent antioxidant to protect cells against oxidative damage from free radicals.

The hallmarks of Bio C’s lipid metabolite vitamin C formula (17)(18)(19):

  • Rapid absorption of vitamin C
  • High levels of circulating vitamin C in blood serum
  • Widespread distribution of vitamin C throughout the body
  • Superior cellular vitamin C uptake by T-lymphocyte immune cells

Bio C (PureWay-C®) is a vitamin C-bioflavonoid complex bound in lipid metabolites. Clinical trials show that Bio C (PureWay-C®) reduces the inflammatory marker C-reactive protein levels (17), thus reduces inflammation while protecting the T-lymphocyte immune cells and tissues against inflammatory damage and oxidative stress. (17)(18)(19) The bioflavonoid-vitamin C complex enhances intestinal absorption, leading to high levels of circulating blood serum vitamin C levels (17) and providing potent antioxidant defense and free radical scavenging capabilities (18). The unique lipid metabolite carriers effectively transport the vitamin C complex into the cells, including uptake by the T-lymphocyte immune cells. (17)(18)

Key features:

  • Reduces C-reactive protein. Prevents vitamin C deficiency
  • Reduces inflammation
  • Reduce inflammation related to lung and respiratory conditions
  • Supports immune function and is a potent antioxidant


The Fullscript Integrative Medical Advisory team has developed or collected these protocols from practitioners and supplier partners to help health care practitioners make decisions when building treatment plans. By adding this protocol to your Fullscript template library, you understand and accept that the recommendations in the protocol are for initial guidance and may not be appropriate for every patient.

View template in-app
  1. Kemmerich, B., Eberhardt, R., Stammer, H. Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled clinical trial. Arzneimittelforschung. 2006;56(9):652-60.
  2. EMEA 2007. European Medicines Agency. Community Monograph on Foeniculum vulgare Miller. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 6 August 2007.
  3. Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
  4. EMA 2014. European Medicines Agency. Community Monograph on Thymus vulgaris L. and Thymus zygis L., Herba. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), February 06 2014. [Accessed 2019 May 23]. Available from:
  5. Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
  6. Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
  7. ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
  8. Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
  9. Tiwari, M. The Role of Serratiopeptidase in the Resolution of Inflammation. Asian J Pharm Sci. 2017 May;12(3):209-215.
  10. Jadhav SB, Shah N, Rathi A, Rathi V, Rathi A. Serratiopeptidase: Insights into the Therapeutic Applications. Biotechnol Rep (Amst). 2020 Oct 17;28:e00544.
  11. Ai-Khateeb T.H., Nusair Y. Effect of Proteolytic Enzyme Serrapeptase on Swelling, Pain and Trism
  12. After Surgical Extraction of Mandibular Third Molars. Int. J. Oral Maxillofac. Surg. 2008;37:264–268
  13. Shimura S., Okubo T., Maeda S., et al. Effect of Expectorants on Relaxation Behavior of Sputum Viscoelasticity In Vivo. Biorheology. 1983;20(5):677-83.
  14. Majima, Y. Mucoactive Medications and Airway Disease. Dept of Otorhinolaryngology, Mie University School of Medicine, Japan. Sept 2002.
  15. Nakamura S., Hashimoto Y., Mikami, M., et al. Effect of the Proteolytic Enzyme Serrapeptase in Patients with Chronic Airway Disease. Respirology. 2003;8:316–320.
  16. Mazzone A, Catalani M, Costanzo M, et al. Evaluation of serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology : a multicentre, double-blind, randomized trial versus placebo. Journal of International Medical Research 1990;18:379-388.
  17. Tachibana M, Mizukoshi O, Harada Y, et al. A multi-centre, double-blind study of serrapeptase versus placebo in post-antrotomy buccal swelling. Pharmatherapeutica 1984;3(8):526-530.
  18. Pancorbo, D., Vazquez, C., Fletcher, M.A. Vitamin C-lipid metabolites: uptake and retention and effect on plasma C-reactive protein and oxidized LDL levels in healthy volunteers. Clinical Trial, Med Sci Monit, 2008 Nov;14(11):CR547-51. University of Miami School of Medicine.
  19. Weeks, B.S., Perez, P.P. Absorption rates and free radical scavenging values of vitamin C-lipid metabolites in human lymphoblastic cells. Med Sci Monit, 2007 Oct;13(10):BR205-10. Adelphi University, Garden City, NY.
  20. Weeks, B.S., Perez, P.P. A novel vitamin C preparation enhances neurite formation and fibroblast adhesion and reduces xenobiotic-induced T-cell hyperactivation. Med Sci Monit, 2007 Mar;13(3):BR51-8. Aldelphi University.